Davies Sarah L, Gibbons Claire E, Vizard Thomas, Ward Donald T
The Univ. of Manchester, Faculty of Life Sciences, Core Technology Facility, 46 Grafton St., Manchester, M13 9NT, UK.
Am J Physiol Cell Physiol. 2006 Jun;290(6):C1543-51. doi: 10.1152/ajpcell.00482.2005. Epub 2006 Jan 11.
The Ca2+-sensing receptor (CaR) is a pleiotropic, type III G protein-coupled receptor (GPCR) that associates functionally with the cytoskeletal protein filamin. To investigate the effect of CaR signaling on the cytoskeleton, human embryonic kidney (HEK)-293 cells stably transfected with CaR (CaR-HEK) were incubated with CaR agonists in serum-free medium for up to 3 h. Addition of the calcimimetic NPS R-467 or exposure to high extracellular Ca2+ or Mg2+ levels elicited actin stress fiber assembly and process retraction in otherwise stellate cells. These responses were ablated by cotreatment with the calcilytic NPS 89636 and were absent in vector-transfected HEK-293 cells. Cotreatment with the Rho kinase inhibitors Y-27632 and H1152 attenuated the CaR-induced morphological change but not intracellular Ca2+ (Ca2+(i)) mobilization or ERK activation, although transfection with a dominant-negative RhoA-binding protein also inhibited calcimimetic-induced actin stress fiber assembly. CaR effects on morphology were unaffected by inhibition of G(q/11) or G(i/o) signaling, epidermal growth factor receptor, or the metalloproteinases. In contrast, CaR-induced cytoskeletal changes were not induced by the aromatic amino acids, treatments that also failed to potentiate CaR-induced ERK activation despite inducing Ca2+(i) mobilization. Together, these data establish that CaR can elicit Rho-mediated changes in stress fiber assembly and cell morphology, which could contribute to the receptor's physiological actions. In addition, this study provides further evidence that aromatic amino acids elicit differential signaling from other CaR agonists.
钙敏感受体(CaR)是一种多效性的III型G蛋白偶联受体(GPCR),在功能上与细胞骨架蛋白细丝蛋白相关联。为了研究CaR信号传导对细胞骨架的影响,将稳定转染了CaR的人胚肾(HEK)-293细胞(CaR-HEK)在无血清培养基中与CaR激动剂孵育长达3小时。添加拟钙剂NPS R-467或暴露于高细胞外钙或镁水平会引发原本呈星状的细胞中的肌动蛋白应激纤维组装和突起回缩。这些反应可通过与钙解剂NPS 89636共同处理而消除,并且在载体转染的HEK-293细胞中不存在。用Rho激酶抑制剂Y-27632和H1152共同处理可减弱CaR诱导的形态变化,但不影响细胞内钙(Ca2+(i))动员或ERK激活,尽管用显性负性RhoA结合蛋白转染也可抑制拟钙剂诱导的肌动蛋白应激纤维组装。CaR对形态的影响不受G(q/11)或G(i/o)信号传导、表皮生长因子受体或金属蛋白酶抑制的影响。相比之下,芳香族氨基酸不会诱导CaR诱导的细胞骨架变化,这些处理尽管诱导了Ca2+(i)动员,但也未能增强CaR诱导的ERK激活。总之,这些数据表明CaR可引发Rho介导的应激纤维组装和细胞形态变化,这可能有助于该受体的生理作用。此外,本研究进一步证明芳香族氨基酸引发的信号传导与其他CaR激动剂不同。